Skip to main content
Premium Trial:

Request an Annual Quote

Rebus Biosystems Closes $20M Series B Financing Round

NEW YORK – Rebus Biosystems, most recently known as Optical Biosystems, announced Thursday it has closed a $20 million Series B financing round, led by Illumina Ventures.

Lifecore Partners, Ncore Ventures, Xolon Invest, CTK Investments, Ray, Seegene Medical Foundation, LabGenomics, and Timefolio Asset Management joined the round.

"The ability of [Rebus Biosystems'] technology to increase throughput, without compromising biological fidelity, will offer spatial analysis to researchers throughout the scientific community," Illuminva Ventures Partners Tom Willis said in a statement.

The Santa Clara, California-based firm's technology includes the patented synthetic aperture optics (SAO) system, which can detect labeled gene transcripts with high-resolution imaging. Founded in 2006 by current CTO Josh Ryu and others, the firm has also been called Solametrix and LightSpeed Genomics. In previous incarnations, the firm has attempted to apply the technology to next-generation sequencing and gene expression analysis.

Rebus Biosystems said it plans to launch its instrument and assay kits for spatial transcriptomics in early 2021.

Illumina Ventures has also participated in funding rounds this year for Stilla Technologies, Genome Medical, and DNA Script.

The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.